Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients
Optimizing treatments for type 2 diabetes mellitus (T2DM) remains an urgent issue. In addition to T2DM treatment strategies, such as glycaemic goals (glucose and glycated haemoglobin ? HbА1c) among different patient populations, the influence of glycaemic variability (GV) on the prognosis of patient...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2014-12-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/6406 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849327363452567552 |
|---|---|
| author | Alina Babenko Elena Ivanovna Krasilnikova Nikolay Pavlovich Likhonosov Anna Pavlovna Likhonosova Elena Nikolaevna Grineva |
| author_facet | Alina Babenko Elena Ivanovna Krasilnikova Nikolay Pavlovich Likhonosov Anna Pavlovna Likhonosova Elena Nikolaevna Grineva |
| author_sort | Alina Babenko |
| collection | DOAJ |
| description | Optimizing treatments for type 2 diabetes mellitus (T2DM) remains an urgent issue. In addition to T2DM treatment strategies, such as glycaemic goals (glucose and glycated haemoglobin ? HbА1c) among different patient populations, the influence of glycaemic variability (GV) on the prognosis of patients with T2DM is also important. According to recent data, GV is associated with cardiovascular complications arising from T2DM. However, although the influence of GV on the development of vascular complications arising from diabetes and underlying mechanisms has been extensively investigated, few studies have investigated the effects of different glucose-lowering medications on GV, and there are even fewer reviews of this topic. This type of analysis is highly relevant, particularly because new classes of antidiabetic medications with potent glucose-dependent insulinotropic effects have been developed. These include groups of drugs that mimic or enhance incretin activity, such as glucagon-like peptide (GLP)-1 analogues/mimetics and dipeptidyl peptidase (DPP)-4 inhibitors. A glucose-dependent mechanism suggests that these groups of antidiabetic medications have beneficial effects on GV. Thus, the current study focusses on the comparative analysis of drugs based on their incretin effects (GLP-1 analogues/mimetics and DPP-4 inhibitors) and оther antidiabetic medications with regard to GV in the patients with T2DM. |
| format | Article |
| id | doaj-art-eff73a7fd76a4619b9da53893fae77f0 |
| institution | Kabale University |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2014-12-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-eff73a7fd76a4619b9da53893fae77f02025-08-20T03:47:53ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782014-12-01174728010.14341/DM2014472-806454Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patientsAlina Babenko0Elena Ivanovna Krasilnikova1Nikolay Pavlovich Likhonosov2Anna Pavlovna Likhonosova3Elena Nikolaevna Grineva4Federal Almazov Medical Research Centre; St. Petersburg First Pavlov State Medical University, Saint-PetersburgFederal Almazov Medical Research Centre; St. Petersburg First Pavlov State Medical University, Saint-PetersburgSt. Petersburg First Pavlov State Medical University, Saint-PetersburgSt. Petersburg First Pavlov State Medical University, Saint-PetersburgFederal Almazov Medical Research Centre; St. Petersburg First Pavlov State Medical University, Saint-PetersburgOptimizing treatments for type 2 diabetes mellitus (T2DM) remains an urgent issue. In addition to T2DM treatment strategies, such as glycaemic goals (glucose and glycated haemoglobin ? HbА1c) among different patient populations, the influence of glycaemic variability (GV) on the prognosis of patients with T2DM is also important. According to recent data, GV is associated with cardiovascular complications arising from T2DM. However, although the influence of GV on the development of vascular complications arising from diabetes and underlying mechanisms has been extensively investigated, few studies have investigated the effects of different glucose-lowering medications on GV, and there are even fewer reviews of this topic. This type of analysis is highly relevant, particularly because new classes of antidiabetic medications with potent glucose-dependent insulinotropic effects have been developed. These include groups of drugs that mimic or enhance incretin activity, such as glucagon-like peptide (GLP)-1 analogues/mimetics and dipeptidyl peptidase (DPP)-4 inhibitors. A glucose-dependent mechanism suggests that these groups of antidiabetic medications have beneficial effects on GV. Thus, the current study focusses on the comparative analysis of drugs based on their incretin effects (GLP-1 analogues/mimetics and DPP-4 inhibitors) and оther antidiabetic medications with regard to GV in the patients with T2DM.https://www.dia-endojournals.ru/jour/article/view/6406continuous glucose monitoringglycaemic variabilityincretinsglp-1 analogues/mimeticsdpp-4 inhibitors |
| spellingShingle | Alina Babenko Elena Ivanovna Krasilnikova Nikolay Pavlovich Likhonosov Anna Pavlovna Likhonosova Elena Nikolaevna Grineva Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients Сахарный диабет continuous glucose monitoring glycaemic variability incretins glp-1 analogues/mimetics dpp-4 inhibitors |
| title | Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients |
| title_full | Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients |
| title_fullStr | Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients |
| title_full_unstemmed | Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients |
| title_short | Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients |
| title_sort | different antihyperglycaemic drug effects on glycaemic variability in type 2 diabetic patients |
| topic | continuous glucose monitoring glycaemic variability incretins glp-1 analogues/mimetics dpp-4 inhibitors |
| url | https://www.dia-endojournals.ru/jour/article/view/6406 |
| work_keys_str_mv | AT alinababenko differentantihyperglycaemicdrugeffectsonglycaemicvariabilityintype2diabeticpatients AT elenaivanovnakrasilnikova differentantihyperglycaemicdrugeffectsonglycaemicvariabilityintype2diabeticpatients AT nikolaypavlovichlikhonosov differentantihyperglycaemicdrugeffectsonglycaemicvariabilityintype2diabeticpatients AT annapavlovnalikhonosova differentantihyperglycaemicdrugeffectsonglycaemicvariabilityintype2diabeticpatients AT elenanikolaevnagrineva differentantihyperglycaemicdrugeffectsonglycaemicvariabilityintype2diabeticpatients |